Bull
$44.59
Scenario price
$5.620
-1.716 (-30.53%)At close
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.
BMO Capital
$11
2026-10-06
BMO Capital
2026-10-06
Price Target
$11
UBS
$10
2026-10-05
UBS
2026-10-05
Price Target
$10
Seaport Research
$21
2026-08-04
Seaport Research
2026-08-04
Price Target
$21
RBC Capital
$11
2026-08-03
RBC Capital
2026-08-03
Price Target
$11
Morgan Stanley
$12
2026-07-31
Morgan Stanley
2026-07-31
Price Target
$12
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

FMC Corporation Stock Plummets 32.4% Due to Downgraded Guidance

FMC Cuts Q3 Outlook Significantly Amidst Inventory Challenges

Tech Stocks Decline While Consumer Staples Rise

Block & Leviton Investigates FMC for Potential Securities Violations

FMC Submits New Herbicide Application
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).
FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.
21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.